A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis. Sigurgeirsson B, van Rossem K, Malahias S, Raterink K. J Am Acad Dermatol
Here is the original post:
Albaconazole for onychomycosis